18.26
price up icon1.11%   0.20
pre-market  プレマーケット:  18.23   -0.03   -0.16%
loading
前日終値:
$18.06
開ける:
$18.1
24時間の取引高:
7.94M
Relative Volume:
0.70
時価総額:
$1.78B
収益:
$2.23B
当期純損益:
$-248.39M
株価収益率:
-6.7881
EPS:
-2.69
ネットキャッシュフロー:
$-697.55M
1週間 パフォーマンス:
-9.51%
1か月 パフォーマンス:
+53.06%
6か月 パフォーマンス:
-82.91%
1年 パフォーマンス:
-86.99%
1日の値動き範囲:
Value
$17.57
$18.30
1週間の範囲:
Value
$17.57
$20.66
52週間の値動き範囲:
Value
$10.41
$140.97

Sarepta Therapeutics Inc Stock (SRPT) Company Profile

Name
名前
Sarepta Therapeutics Inc
Name
セクター
Healthcare (1150)
Name
電話
617-274-4000
Name
住所
215 FIRST STREET, CAMBRIDGE, MA
Name
職員
1,372
Name
Twitter
@sarepta
Name
次回の収益日
2025-08-01
Name
最新のSEC提出書
Name
SRPT's Discussions on Twitter

SRPT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SRPT
Sarepta Therapeutics Inc
18.26 2.05B 2.23B -248.39M -697.55M -2.69
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
387.18 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.65 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.20 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
708.09 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
308.91 37.96B 3.81B -644.79M -669.77M -6.24

Sarepta Therapeutics Inc Stock (SRPT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-29 アップグレード Barclays Underweight → Equal Weight
2025-07-29 開始されました Bernstein Mkt Perform
2025-07-29 繰り返されました H.C. Wainwright Sell
2025-07-29 アップグレード JP Morgan Underweight → Neutral
2025-07-29 アップグレード Oppenheimer Perform → Outperform
2025-07-28 ダウングレード Barclays Equal Weight → Underweight
2025-07-25 ダウングレード JP Morgan Neutral → Underweight
2025-07-24 開始されました Citigroup Sell
2025-07-23 ダウングレード BofA Securities Neutral → Underperform
2025-07-22 ダウングレード Barclays Overweight → Equal Weight
2025-07-21 ダウングレード Deutsche Bank Buy → Hold
2025-07-21 ダウングレード Leerink Partners Outperform → Market Perform
2025-07-21 ダウングレード Mizuho Outperform → Neutral
2025-07-21 ダウングレード Needham Hold → Underperform
2025-07-21 ダウングレード UBS Buy → Neutral
2025-07-18 ダウングレード Needham Buy → Hold
2025-06-20 ダウングレード William Blair Outperform → Mkt Perform
2025-06-18 ダウングレード TD Cowen Buy → Hold
2025-06-17 開始されました Wolfe Research Peer Perform
2025-06-16 ダウングレード BMO Capital Markets Outperform → Market Perform
2025-06-16 ダウングレード BofA Securities Buy → Neutral
2025-06-16 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-06-16 ダウングレード H.C. Wainwright Neutral → Sell
2025-06-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-06-16 ダウングレード Piper Sandler Overweight → Neutral
2025-06-06 アップグレード Scotiabank Sector Perform → Sector Outperform
2025-05-08 ダウングレード Evercore ISI Outperform → In-line
2025-04-11 開始されました Wells Fargo Overweight
2025-04-02 アップグレード H.C. Wainwright Sell → Neutral
2025-03-31 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-11 開始されました Deutsche Bank Hold
2024-11-27 繰り返されました Needham Buy
2024-11-25 開始されました H.C. Wainwright Sell
2024-11-07 アップグレード Cantor Fitzgerald Neutral → Overweight
2024-10-21 開始されました Jefferies Buy
2024-10-10 再開されました Raymond James Outperform
2024-07-29 アップグレード RBC Capital Mkts Sector Perform → Outperform
2024-06-26 ダウングレード Citigroup Buy → Neutral
2024-05-31 開始されました Piper Sandler Overweight
2024-05-28 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-05-14 アップグレード Oppenheimer Perform → Outperform
2024-01-31 開始されました BMO Capital Markets Outperform
2023-12-13 再開されました Citigroup Buy
2023-12-12 開始されました Deutsche Bank Buy
2023-11-21 開始されました Wedbush Outperform
2023-10-31 ダウングレード Cantor Fitzgerald Overweight → Neutral
2023-10-31 ダウングレード Oppenheimer Outperform → Perform
2023-06-23 ダウングレード Evercore ISI Outperform → In-line
2023-04-26 開始されました SMBC Nikko Outperform
2023-04-04 開始されました Citigroup Buy
2023-03-01 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-12-22 繰り返されました BTIG Research Buy
2022-12-16 アップグレード UBS Neutral → Buy
2022-04-04 再開されました Cantor Fitzgerald Overweight
2022-01-05 繰り返されました Needham Buy
2021-12-09 アップグレード Oppenheimer Perform → Outperform
2021-11-05 アップグレード JP Morgan Neutral → Overweight
2021-09-15 アップグレード Guggenheim Neutral → Buy
2021-08-05 アップグレード JP Morgan Underweight → Neutral
2021-06-15 開始されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Neutral
2021-01-12 ダウングレード Citigroup Buy → Neutral
2021-01-11 ダウングレード UBS Buy → Neutral
2021-01-08 ダウングレード JP Morgan Overweight → Underweight
2021-01-08 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-01-08 ダウングレード Raymond James Outperform → Mkt Perform
2020-11-11 開始されました Berenberg Hold
2020-10-28 開始されました UBS Buy
2020-08-25 開始されました Raymond James Outperform
2020-08-20 ダウングレード Credit Suisse Outperform → Neutral
2020-03-31 開始されました Mizuho Buy
2019-11-01 開始されました Guggenheim Buy
2019-08-21 繰り返されました Needham Buy
2019-07-09 繰り返されました Morgan Stanley Overweight
2019-07-01 繰り返されました RBC Capital Mkts Outperform
2019-04-12 開始されました Evercore ISI Outperform
2019-03-11 繰り返されました Credit Suisse Outperform
2018-10-12 開始されました Bernstein Outperform
2018-10-01 開始されました Cantor Fitzgerald Overweight
2018-09-26 繰り返されました RBC Capital Mkts Outperform
2018-09-14 再開されました BofA/Merrill Buy
2018-09-06 開始されました Credit Suisse Outperform
2018-08-01 アップグレード Morgan Stanley Equal-Weight → Overweight
2018-06-21 繰り返されました Robert W. Baird Outperform
2018-06-20 繰り返されました Needham Buy
2018-06-19 繰り返されました H.C. Wainwright Buy
すべてを表示

Sarepta Therapeutics Inc (SRPT) 最新ニュース

pulisher
03:54 AM

Elanco Animal Health to Replace Sarepta Therapeutics in S&P MidCap 400 - MarketScreener

03:54 AM
pulisher
01:04 AM

Trading Systems Reacting to (SRPT) Volatility - news.stocktradersdaily.com

01:04 AM
pulisher
Aug 26, 2025

Investors in Sarepta Therapeutics, Inc. (SRPT): Protect Your RightsContact Levi & Korsinsky Before August 25, 2025 - Newsfile

Aug 26, 2025
pulisher
Aug 25, 2025

SRPT Stock Plunge: Time to Panic? - StocksToTrade

Aug 25, 2025
pulisher
Aug 25, 2025

SAREPTA FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Aug 25, 2025
pulisher
Aug 25, 2025

Securities Lawsuit Alert: Sarepta Therapeutics, Inc. (SRPT)Contact Levi & Korsinsky Before August 25, 2025 - Barchart.com

Aug 25, 2025
pulisher
Aug 25, 2025

Class Action Filed Against Sarepta Therapeutics, Inc. (SRPT) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire

Aug 25, 2025
pulisher
Aug 25, 2025

Sarepta Therapeutics (SRPT): Assessing Valuation After Lawsuits and FDA Scrutiny Over ELEVIDYS Safety Concerns - Yahoo Finance

Aug 25, 2025
pulisher
Aug 25, 2025

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - WV News

Aug 25, 2025
pulisher
Aug 22, 2025

INVESTOR DEADLINE MONDAY: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSRPT - PR Newswire

Aug 22, 2025
pulisher
Aug 22, 2025

Sarepta Therapeutics: A Strong Opportunity Amidst The Panic (NASDAQ:SRPT) - Seeking Alpha

Aug 22, 2025
pulisher
Aug 21, 2025

SRPT FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, - GlobeNewswire

Aug 21, 2025
pulisher
Aug 21, 2025

Sarepta Gets Breathing Room With $700 Million Debt Restructuring - Bloomberg

Aug 21, 2025
pulisher
Aug 21, 2025

Sarepta Therapeutics Announces Refinancing of Approximately $700 Million of 1.25% Convertible Senior Notes due 2027 - Business Wire

Aug 21, 2025
pulisher
Aug 20, 2025

Jim Cramer on Sarepta Therapeutics: "If it Goes Up, You Gotta Do Some Selling" - Yahoo Finance

Aug 20, 2025
pulisher
Aug 20, 2025

SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Aug 20, 2025
pulisher
Aug 20, 2025

SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Aug 20, 2025
pulisher
Aug 20, 2025

2025-08-20 | Lost Money on Sarepta Therapeutics, Inc. (SRPT)? Contact Levi & Korsinsky Before August 25, 2025 to Join Class Action | NDAQ:SRPT | Press Release - Stockhouse

Aug 20, 2025
pulisher
Aug 20, 2025

SRPT Investors Have the Opportunity to Lead the Sarepta - GlobeNewswire

Aug 20, 2025
pulisher
Aug 20, 2025

SRPT Investors Have the Opportunity to Lead the Sarepta Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar

Aug 20, 2025
pulisher
Aug 20, 2025

BofA Securities Adjusts Price Target on Sarepta Therapeutics to $17 From $10, Maintains Underperform Rating - MarketScreener

Aug 20, 2025
pulisher
Aug 20, 2025

What MACD and RSI say about Sarepta Therapeutics Inc.Profit Target & Risk Controlled Swing Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Will Sarepta Therapeutics Inc. bounce back from current supportWeekly Risk Summary & Fast Exit/Entry Strategy Plans - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Precision Trading with Sarepta Therapeutics Inc. (SRPT) Risk Zones - news.stocktradersdaily.com

Aug 19, 2025
pulisher
Aug 19, 2025

Sarepta Therapeutics, Inc. Investors: Please contact the - GlobeNewswire

Aug 19, 2025
pulisher
Aug 19, 2025

Sarepta Therapeutics, Inc. (SRPT) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 25, 2025 Deadline - Barchart.com

Aug 19, 2025
pulisher
Aug 19, 2025

Sarepta Therapeutics, Inc. Class Action: Levi & Korsinsky - GlobeNewswire

Aug 19, 2025
pulisher
Aug 19, 2025

Earnings visualization tools for Sarepta Therapeutics Inc.2025 EndofYear Setup & Intraday High Probability Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Burned by Sarepta Therapeutics, Inc.? Contact Levi & Korsinsky to SueWallSt and Fight Back - ACCESS Newswire

Aug 19, 2025
pulisher
Aug 19, 2025

SRPT’s Stock Dilemma: Sarepta Therapeutics Inc’s Market Performance and Outlook - investchronicle.com

Aug 19, 2025
pulisher
Aug 19, 2025

Shareholders that lost money on Sarepta Therapeutics, Inc.(SRPT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - Morningstar

Aug 19, 2025
pulisher
Aug 19, 2025

SRPT SECURITIES: Sarepta Therapeutics, Inc. Shareholders that Lost Money may have been Affected by Fraud -- Contact BFA Law before the Class Action Deadline (NASDAQ:SRPT) - GlobeNewswire

Aug 19, 2025
pulisher
Aug 19, 2025

Sarepta Therapeutics, Inc. $SRPT Shares Sold by Maryland State Retirement & Pension System - Defense World

Aug 19, 2025
pulisher
Aug 19, 2025

PNC Financial Services Group Inc. Has $149,000 Stock Holdings in Sarepta Therapeutics, Inc. $SRPT - Defense World

Aug 19, 2025
pulisher
Aug 18, 2025

Sarepta Therapeutics Inc. stock daily chart insightsJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Class Action Filed Against Sarepta Therapeutics, Inc. (SRPT) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire

Aug 18, 2025
pulisher
Aug 18, 2025

Robbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

Contact The Gross Law Firm by August 25, 2025 Deadline to - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

Arrowhead (ARWR) Climbs 24.9% on $100-Million Licensing Revenue - Yahoo Finance

Aug 18, 2025
pulisher
Aug 18, 2025

Sarepta Therapeutics (SRPT) August 25, 2025 Lead Plaintiff - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

Investors In Sarepta Therapeutics, Inc. (SRPT): Protect Your RightsContact Levi & Korsinsky Before August 25, 2025 - Barchart.com

Aug 18, 2025
pulisher
Aug 18, 2025

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc.(SRPT) Shareholders - Morningstar

Aug 18, 2025
pulisher
Aug 18, 2025

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

SRPT LOSSES: Sarepta Therapeutics, Inc. Investors with Losses are Encouraged to Contact BFA Law before Expiration of August 25 Class Action Deadline - Newsfile

Aug 18, 2025
pulisher
Aug 18, 2025

How the Moms and Dads of Patients Won Sarepta’s Drug a Reprieve - Bloomberg.com

Aug 18, 2025
pulisher
Aug 18, 2025

SRPT INVESTOR NOTICE: Robbins Geller Ruman & Dowd LLP - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

Will Sarepta Therapeutics Inc. outperform the marketPortfolio Update Summary & Pattern Based Trade Signal System - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Sarepta Therapeutics, Inc. $SRPT Shares Sold by LPL Financial LLC - Defense World

Aug 18, 2025
pulisher
Aug 18, 2025

SRPT LOSS ALERT: Sarepta Therapeutics, Inc. Investors with - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities LawsuitContact the DJS Law Group Before the Final DeadlineSRPT - MarketScreener

Aug 18, 2025
pulisher
Aug 17, 2025

How Sarepta Therapeutics Inc. (SRPT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Aug 17, 2025

Sarepta Therapeutics Inc (SRPT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Sarepta Therapeutics Inc (SRPT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Barry Richard
Director
May 16 '25
Option Exercise
32.63
12,350
402,981
2,966,667
Barry Richard
Director
May 13 '25
Option Exercise
19.23
20,246
389,359
2,954,317
Nicaise Claude
Director
Mar 12 '25
Option Exercise
25.18
9,746
245,404
30,303
Nicaise Claude
Director
Mar 12 '25
Sale
99.64
2,491
248,203
27,812
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
大文字化:     |  ボリューム (24 時間):